Sound Bioventures is a venture capital fund that invests in private companies in Europe and the USA developing medicines in specialty therapeutic areas. They focus on companies that are about-to-be clinical or already in the clinical stage. The firm originated as a Danish-Swedish project, reflecting its international approach and ambition to invest beyond Scandinavia. The name "Sound Bioventures" reflects the founders' geographic location near the Øresund (the Sound) between Denmark and Sweden, symbolizing the busy shipping lane and the Medicon Valley region, a hub for life sciences in Scandinavia. It also alludes to financially robust investments and investments promoting health. The firm emphasizes a straightforward, transparent, and long-term oriented approach to investing. They prioritize what is best for the company at every stage of their decision-making process, positioning themselves as co-investors with a strong ethical compass.
Preferred startup development maturity for initial funding deployment.
Specialty therapeutics
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...